Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,578
archived clinical trials in
Skin and Soft Tissue Infections

Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
Phase II Study of Prednisolone/Methylprednisolone Absorption in Children With Juvenile Dermatomyositis
Status: Archived
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
Phase II Study of Prednisolone/Methylprednisolone Absorption in Children With Juvenile Dermatomyositis
Status: Archived
Updated: 1/1/1970
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders
High Dose Cyclophosphamide & ATG With Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders: A Phase I Trial
Status: Archived
Northwestern University
mi
from
Chicago, IL
Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders
High Dose Cyclophosphamide & ATG With Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders: A Phase I Trial
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
University of Alabama at Birmingham
mi
from
Birmingham, AL
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
University of Alabama at Birmingham
mi
from
Birmingham, AL
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Children's Hospital San Diego & University of California San Diego
mi
from
San Diego, CA
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
Children's Hospital San Diego & University of California San Diego
mi
from
San Diego, CA
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
University of Miami Hospital
mi
from
Miami, FL
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
University of Miami Hospital
mi
from
Miami, FL
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Northwestern University Feinberg School of Medicine Dept of Dermatology
mi
from
Chicago, IL
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
Northwestern University Feinberg School of Medicine Dept of Dermatology
mi
from
Chicago, IL
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
University of Massachusetts Worcester
mi
from
Worcester, MA
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
University of Massachusetts Worcester
mi
from
Worcester, MA
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Washington University
mi
from
St. Louis, MO
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
St Vincent Health Center
mi
from
Erie, PA
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
St Vincent Health Center
mi
from
Erie, PA
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Vanderbilt University Medical Center
mi
from
Nashville, TN
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Nashville, TN
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa
Status: Archived
Updated: 1/1/1970
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Pilot Study Comparing Remicade (Infliximab) vs. Standard Care in the Treatment of Toxic Epidermal Necrolysis
Status: Archived
Loyola University Medical Center
mi
from
Proviso, IL
Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Pilot Study Comparing Remicade (Infliximab) vs. Standard Care in the Treatment of Toxic Epidermal Necrolysis
Status: Archived
Updated: 1/1/1970
Loyola University Medical Center
mi
from
Proviso, IL
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Veterans Affairs Medical Center - Lakeside Chicago
mi
from
Chicago, IL
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - Lakeside Chicago
mi
from
Chicago, IL
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
VA Medical Center, Augusta
mi
from
Augusta, GA
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Updated: 1/1/1970
VA Medical Center, Augusta
mi
from
Augusta, GA
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Updated: 1/1/1970
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
St Louis, MO
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Updated: 1/1/1970
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
St Louis, MO
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)
Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury
Status: Archived
Updated: 1/1/1970
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
Status: Archived
University of California, Davis Department of Dermatology
mi
from
Sacramento, CA
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
Status: Archived
Updated: 1/1/1970
University of California, Davis Department of Dermatology
mi
from
Sacramento, CA
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Pilot Study of Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) In Children With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Status: Archived
Children's Medical Center of Dallas
mi
from
Dallas, TX
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Pilot Study of Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) In Children With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Status: Archived
Updated: 1/1/1970
Children's Medical Center of Dallas
mi
from
Dallas, TX
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Pilot Study of Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) In Children With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Status: Archived
Children's Hospital Central California
mi
from
Madera, CA
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Pilot Study of Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) In Children With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Status: Archived
Updated: 1/1/1970
Children's Hospital Central California
mi
from
Madera, CA
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Pilot Study of Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) In Children With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Status: Archived
Morgan Stanley Children's Hospital
mi
from
New York, NY
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Pilot Study of Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) In Children With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Status: Archived
Updated: 1/1/1970
Morgan Stanley Children's Hospital
mi
from
New York, NY
Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)
Pilot Study of Acitretin for Treatment of Erlotinib-induced Skin Rash
Status: Archived
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)
Pilot Study of Acitretin for Treatment of Erlotinib-induced Skin Rash
Status: Archived
Updated: 1/1/1970
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Southbay Pharma Research
mi
from
Buena Park, CA
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
Southbay Pharma Research
mi
from
Buena Park, CA
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
eStudySite
mi
from
Chula Vista, CA
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
eStudySite
mi
from
Chula Vista, CA
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Healthcare Partners Medical Group
mi
from
Carson, CA
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
Healthcare Partners Medical Group
mi
from
Carson, CA
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Central Florida Internists
mi
from
St Cloud, FL
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
Central Florida Internists
mi
from
St Cloud, FL
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Ronald Barbour, MD
mi
from
Temple Terrace, FL
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
Ronald Barbour, MD
mi
from
Temple Terrace, FL
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Southeastern Regional Research Group
mi
from
Columbus, GA
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
Southeastern Regional Research Group
mi
from
Columbus, GA
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
eStudySite
mi
from
Las Vegas, NV
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
eStudySite
mi
from
Las Vegas, NV
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Ravi Kamepalli, MD
mi
from
Lima, OH
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
Ravi Kamepalli, MD
mi
from
Lima, OH
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Health Concepts
mi
from
Rapid City, SD
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
Health Concepts
mi
from
Rapid City, SD
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Jennifer Johnson-Caldwell, MD
mi
from
Houston, TX
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
Jennifer Johnson-Caldwell, MD
mi
from
Houston, TX
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Alan Nolasco, MD
mi
from
Houston, TX
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid
Status: Archived
Updated: 1/1/1970
Alan Nolasco, MD
mi
from
Houston, TX
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Allergy, Asthma & Immunology, Assoc, Ltd.
mi
from
Scottsdale, AZ
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Allergy, Asthma & Immunology, Assoc, Ltd.
mi
from
Scottsdale, AZ
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
UCLA Medical Center
mi
from
Los Angeles, CA
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
UCLA Medical Center
mi
from
Los Angeles, CA
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Donald S. Levy, M.D.
mi
from
Orange, CA
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Donald S. Levy, M.D.
mi
from
Orange, CA
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Family Allergy and Asthma Center
mi
from
Atlanta, GA
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Family Allergy and Asthma Center
mi
from
Atlanta, GA
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Institute for Asthma and Allergy
mi
from
Wheaton, MD
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Institute for Asthma and Allergy
mi
from
Wheaton, MD
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Winthrop University Hospital
mi
from
Mineola, NY
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Winthrop University Hospital
mi
from
Mineola, NY
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Mark J. Florian, MD, PA
mi
from
Bryan, TX
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Mark J. Florian, MD, PA
mi
from
Bryan, TX
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
AARA Research Center
mi
from
Dallas, TX
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
AARA Research Center
mi
from
Dallas, TX
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Allergy and Asthma Research Center
mi
from
San Antonio, TX
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Allergy and Asthma Research Center
mi
from
San Antonio, TX
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Marycliff Allergy Specialist
mi
from
Spokane, WA
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Marycliff Allergy Specialist
mi
from
Spokane, WA
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Puget Sound Allergy, Asthma & Immunology
mi
from
Tacoma, WA
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human])
A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks.
Status: Archived
Updated: 1/1/1970
Puget Sound Allergy, Asthma & Immunology
mi
from
Tacoma, WA